← Browse by Condition
Medical Condition
acute respiratory distress syndrome
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for acute respiratory distress syndrome sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — acute respiratory distress syndrome Clinical Trials
How many clinical trials are currently recruiting for acute respiratory distress syndrome?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for acute respiratory distress syndrome, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for acute respiratory distress syndrome?
acute respiratory distress syndrome research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a acute respiratory distress syndrome clinical trial?
Eligibility criteria for acute respiratory distress syndrome trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06188195
Recruiting
Enrollment
500 pts
Location
China
Sponsor
The Second Affiliated Hospital...
NCT05406570
Recruiting
Enrollment
10 pts
Location
France
Sponsor
Hospices Civils de Lyon
NCT03736707
Recruiting
Enrollment
400 pts
Location
China
Sponsor
Daping Hospital and the Resear...
NCT06703073 Phase 2
Recruiting
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP
NCT06586736
Recruiting
Enrollment
100 pts
Location
China
Sponsor
West China Hospital
NCT06066502 Phase 3
Recruiting
Enrollment
1,100 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical ...
NCT04754854
Recruiting
Enrollment
136 pts
Location
Germany
Sponsor
Charite University, Berlin, Ge...
Related Conditions
respiratory distress syndrome acute (1) high frequency oscillatory ventilation (1) preterm (1) conventional mechanical ventilation (1) acute respiratory distress syndrome ards (1) ards (1) ards acute respiratory distress syndrome (1) mechanical ventilation (1) prone positioning (1) respiratory failure (1) extracorporeal membrane oxygenation (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology